(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: A Wingless β-Catenin Agonist That Increases Bone Formation Rate

被引:40
|
作者
Pelletier, Jeffrey C. [1 ]
Lundquist, Joseph T., IV [1 ]
Gilbert, Adam M. [4 ]
Alon, Nipa [4 ]
Bex, Frederick J. [2 ]
Bhat, Bheem M. [2 ]
Bursavich, Mattew G. [4 ]
Coleburn, Valerie E. [2 ]
Felix, Luciana A. [1 ]
Green, Daniel M. [1 ]
Green, Paula [2 ]
Hauze, Diane B. [1 ]
Kharode, Yogendra P. [2 ]
Lam, Ho-Sun [2 ]
Lockhead, Susan R. [3 ]
Magolda, Ronald L. [1 ]
Matteo, Jeanne J. [2 ]
Mehlmann, John F. [1 ]
Milligan, Colleen [2 ]
Murrills, Richard J. [2 ]
Pirrello, Jennifer [2 ]
Selim, Sally [2 ]
Sharp, Michael C. [2 ]
Unwalla, Ray J. [1 ]
Vera, Matthew D. [1 ]
Wrobel, Jay E. [1 ]
Yaworsky, Paul [2 ]
Bodine, Peter V. N. [2 ]
机构
[1] Wyeth Res, Chem Sci, Collegeville, PA 19426 USA
[2] Wyeth Res, Tissue Repair, Collegeville, PA 19426 USA
[3] Wyeth Res, Drug Safety & Metab, Collegeville, PA 19426 USA
[4] Wyeth Res, Chem Sci, Pearl River, NY 10965 USA
关键词
WNT; MUTATION; PATHWAY; OSTEOPOROSIS; INHIBITORS; PROTEINS;
D O I
10.1021/jm9014197
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A high-throughput screening campaign to discover small molecule leads for the treatment of bone disorders concluded with the discovery of a compound with a 2-aminopyrimidine template that targeted the Wnt beta-catenin cellular messaging system. Hit-to-lead in vitro optimization for target activity and molecular properties led to the discovery of (1-(4-(naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine (5, WAY-262611). Compound 5 has excellent pharmacokinetic properties and showed a dose dependent increase in the trabecular bone formation rate in ovariectomized rats following oral administration.
引用
收藏
页码:6962 / 6965
页数:4
相关论文
共 50 条
  • [21] 1-[1-(decahydronaphthalen-1-yl)piperidin-4-yl]indolin-2-one: one of a novel series of nociceptin receptor ligands
    Parrish, DA
    Deschamps, JR
    Jiang, FM
    Zaveri, NT
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2004, 60 : O1253 - O1254
  • [22] N-(4-Chlorophenyl)-4-(pyrimidin-2-yl)piperazine-1-carboxamide
    Li, Yu-Feng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2575 - U1866
  • [23] 1-[3-(Morpholin-4-yl)propyl]-3-[(naphthalen-2-yl)oxy]-4-(3-nitro-phenyl)azetidin-2-one
    Atioglu, Zeliha
    Akkurt, Mehmet
    Jarrahpour, Aliasghar
    Heiran, Roghayeh
    Ozdemir, Namik
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2014, 70 : O833 - +
  • [24] 4-Chloro-N-(pyrimidin-2-yl)aniline
    Akmam, A. Bakar Maizathul
    Abdullah, Zanariah
    Ng, Seik Weng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O94 - U2085
  • [25] 4-Nitrobenzoicacid-N-(pyrimidin-2-yl)aniline (1/1)
    Aznan, Aina Mardia Akhmad
    Abdullah, Zanariah
    Ng, Seik Weng
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O3080 - U1817
  • [26] 1-(Thiophen-2-yl)-N-(4-{(E)-[(thiophen-2yl)methyl]iminomethyl}benzylidene)methanamine
    Chiririwa, Haleden
    Moss, John R.
    Hendricks, Denver
    Meijboom, Reinout
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O3137 - +
  • [27] Metabolism mediated CYP 2B induction by LX6171 (3′-chlorobiphenyl-4-yl)-1-(pyrimidine-2-yl) piperidin-4-yl) methanone) in the rat
    Li, Ling
    Kramer, Jeffrey A.
    Heydorn, William E.
    Nouraldeen, Amr
    Schmidt, James
    Jiang, Jianghong
    Moran, Liam
    Wilson, Alan G. E.
    DRUG METABOLISM REVIEWS, 2009, 41 : 86 - 86
  • [28] 3-{[4-(4-Pyridyl)pyrimidin-2-yl]sulfanylmethyl}benzoic acid
    Zhu, Hai-Bin
    Wang, Hai
    Ji, Jun-Feng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O2347 - U2434
  • [29] 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as σ receptor ligands with agonist σ2 activity
    Berardi, F
    Ferorelli, S
    Abate, C
    Colabufo, NA
    Contino, M
    Perrone, R
    Tortorella, V
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (09) : 2308 - 2317
  • [30] N-[4-(4-Bromophenyl)thiazol-2-yl]4-(piperidin-1-yl)butanamide
    Ghabbour, Hazem A.
    Kadi, Adnan A.
    EI-Subbagh, Hussein I.
    Chia, Tze Shyang
    Fun, Hoong-Kun
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1665 - +